Back

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Biomarkers for heart failure 1 Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speakers

Photo
Doctor Moritake Iguchi

Kyoto Medical Centre, Kyoto (Japan)

Photo
Professor Koji Hasegawa

National Hospital Organization Kyoto Medical Centre, Kyoto (Japan)

6 More presentations in this session

Presentation thumbnail
Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy
Doctor R. Klingenberg (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy
Doctor O. Wozniak (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction
Doctor J. Cunningham (Boston, US)
Abstract Slides
Presentation thumbnail
Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure
Doctor R. Pistulli (Munster, DE)
Abstract Slides
Presentation thumbnail
Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).
Mr C. Kelly (Newcastle, AU)
Abstract Slides

Access the full session

Session thumbnail
Biomarkers for heart failure 1

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources